BackValue Line Asset Allocation Fund Investor Class Overview

Value Line Asset Allocation Fund Investor Class Total Liabilities

Track Value Line Asset Allocation Fund Investor Class's total liabilities ($45M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$45.30M
↓ 3.84% YoYΔ $-1.81M vs prior year quarter

Peer trimmed avg / median

Loading

Value Line Asset Allocation Fund Investor Class Total Liabilities History

Loading

Value Line Asset Allocation Fund Investor Class vs. peers: Total Liabilities Comparison

Loading

Value Line Asset Allocation Fund Investor Class Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Value Line Asset Allocation Fund Investor Class (VLAAX) FAQ

As of the most recent data (January 2024), VLAAX shows a total liabilities of $45M. That compares with $47M in the prior-year period — down 3.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VLAAX's total liabilities is now $45M (was $47M) — a 3.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Value Line Asset Allocation Fund Investor Class is outperforming or lagging.

Tracking VLAAX's total liabilities over time shows whether Value Line Asset Allocation Fund Investor Class is scaling, shrinking, or reshaping that part of the business. The current reading is $45M That compares with $47M in the prior-year period — down 3.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Value Line Asset Allocation Fund Investor Class's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $45M) with ownership activity and broader fundamentals.

Questions & Answers